|
|
|
1374.1 |
Thomas Brinkmeier |
2024/09/07 22:09 |
|
|
|
|
1373.1 |
Thomas Brinkmeier |
2024/09/07 22:09 |
|
|
|
|
1372.1 |
Thomas Brinkmeier |
2024/09/07 22:09 |
|
|
|
|
1371.1 |
Thomas Brinkmeier |
2024/09/07 22:08 |
|
|
|
|
1370.1 |
Thomas Brinkmeier |
2024/08/02 09:58 |
|
|
|
|
1369.1 |
Thomas Brinkmeier |
2024/08/02 09:58 |
Deleted attachment [Varia, N-Klassifikation des Primärtumors beim Melanom nach AJCC 2016.png] |
|
|
|
1368.1 |
Thomas Brinkmeier |
2024/08/02 09:57 |
Deleted attachment [Varia, M-Klassifikation des Primärtumors beim Melanom nach AJCC 2016.png] |
|
|
|
1367.1 |
Thomas Brinkmeier |
2024/08/02 09:57 |
Deleted attachment [Varia, MAP-Kinase-Signalweg mit Inhibitoren.png] |
|
|
|
1366.1 |
Thomas Brinkmeier |
2024/08/02 09:57 |
Deleted attachment [Varia, Immunmodulation-Optionen mit Zielstrukturen der T-Zelle.png] |
|
|
|
1365.1 |
Thomas Brinkmeier |
2024/08/02 09:56 |
Deleted attachment [Varia, T-Klassifikation des Primärtumors beim Melanom nach AJCC 2016.png] |
|
|
|
1364.1 |
Thomas Brinkmeier |
2024/05/19 16:57 |
|
|
|
|
1363.1 |
Thomas Brinkmeier |
2024/05/19 16:56 |
|
|
|
|
1362.1 |
Thomas Brinkmeier |
2024/05/19 16:56 |
|
|
|
|
1361.1 |
Thomas Brinkmeier |
2024/04/07 19:21 |
|
|
|
|
1360.1 |
Thomas Brinkmeier |
2024/04/07 19:21 |
|
|
|
|
1359.1 |
Thomas Brinkmeier |
2024/04/07 19:21 |
|
|
|
|
1358.1 |
Thomas Brinkmeier |
2024/04/07 19:20 |
|
|
|
|
1357.1 |
Thomas Brinkmeier |
2024/04/07 19:20 |
|
|
|
|
1356.1 |
Thomas Brinkmeier |
2024/04/07 19:20 |
|
|
|
|
1355.1 |
Thomas Brinkmeier |
2024/04/07 19:20 |
|